Jul 2 |
Aerovate slashes workforce after failed Phase IIb trial
|
Jun 27 |
The 3 Hottest Stock Downgrades From Last Week
|
Jun 18 |
Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals
|
Jun 17 |
Aerovate Therapeutics Stock Dropped Over 90%. Here’s Why.
|
Jun 17 |
Top Midday Decliners
|
Jun 17 |
Why 90% Of Aerovate Therapeutics' Value Just Went Up In Smoke
|
Jun 17 |
Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday?
|
Jun 17 |
Aerovate Therapeutics slides after its hypertension treatment fails to meet main goal
|
Jun 17 |
Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
|
Jun 11 |
Aerovate: Imatinib Delivery Change Leads To Targeting Of Massive PAH Market
|